Sagimet Biosciences Inc. (NASDAQ:SGMT) Given Average Rating of Buy by Analysts

Sagimet Biosciences Inc. (NASDAQ:SGMT – Get Free Report) has earned a consensus rating of “Buy” from the seven research firms that are currently covering the firm, Marketbeat.com reports. Seven equities research analysts have rated the stock with a buy rating. The average 1-year price objective among analysts that have issued a report on the stock […]

Related Keywords

United States ,Leerink Partnrs ,David Happel ,Sagimet Biosciences ,Hermes Inc ,Silverarc Capital Management ,Nasdaq ,Sagimet Biosciences Inc ,Platinum Investment Management Ltd ,Sagimet Biosciences Company Profile ,Goldman Sachs Group ,Get Free Report ,Investment Management ,Capital Management ,Rock Springs Capital Management ,Get Free ,Biosciences Inc ,Sagimet Biosciences Daily ,